Showing results (611-620 of 682) with videos related to

Sort By:
Pageof 69
International Journal of Cancer|August 28, 2020
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancerPik-Fang Kho, Frederic Amant, Daniela Annibali, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2016
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer SurvivalLara E Sucheston-Campbell, Rikki Cannioto, Alyssa I Clay, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
Nature Communications|July 5, 2020
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancersYan Dora Zhang, Amber N Hurson, Haoyu Zhang, et al.
Circulation|September 26, 2022
Cross-Ancestry Investigation of Venous Thromboembolism Genomic PredictorsFlorian Thibord, Derek Klarin, Jennifer A Brody, et al.
Breast Cancer Research : BCR|April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Scientific Reports|December 2, 2015
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1Timothy H T Cheng, Deborah Thompson, Jodie Painter, et al.
Oncotarget|December 3, 2016
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaborationJennifer B Permuth, Brett Reid, Madalene Earp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2015
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association ConsortiumSharon E Johnatty, Jonathan P Tyrer, Siddhartha Kar, et al.
Pageof 69